Insider Transactions in Q3 2021 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 09
2021
|
Jerry S Lanchbury Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-6.57%
|
$1,600,000
$32.52 P/Share
|
|
Jul 09
2021
|
Jerry S Lanchbury Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+6.08%
|
$1,200,000
$24.15 P/Share
|
|
Jul 07
2021
|
Jerry S Lanchbury Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
32,308
-6.19%
|
$1,033,856
$32.14 P/Share
|
|
Jul 07
2021
|
Jerry S Lanchbury Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,308
+5.58%
|
$840,008
$26.49 P/Share
|